Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. Although O(6)-methylguanine DNA methyltransferase (MGMT) promoter methylation status is an important marker for glioblastoma multiforme (Glioblastoma), there is considerable variability in the clinical outcome of patients with similar methylation profles. OBJECTIVE: We examined whether a MicroRNA (MicroRNA) signature can be identified for predicting clinical outcomes and helping in treatment decisions. METHODS: The differentially expressed MicroRNAs were evaluated in 6 pairs of short- (⩽ 450 days) and long-term survivors (> 450 days) by using microarray. real-time quantitative PCR (qRT-PCR) was applied to further verify screened MicroRNAs with a greater number of samples (n= 48). Meanwhile, functional interpretation of MicroRNA profile was carried out based on MicroRNA-target databases. In addition, MGMT promoter methylation status was tested by means of pyrosequencing (PSQ) testing. RESULTS: Six MicroRNAs were upregulated in the long-term survival group (fold change ⩾ 2.0, P< 0.05). The further verification by qRT-PCR indicated that the increase in let-7g-5p, miR-139-5p, miR-17-5p and miR-9-3p level in long-term survivors was statistically significant. Kaplan-Meier survival analysis showed that high expression of a prognostic 4-MicroRNA signature was significantly associated with good patient survival (p= 0.0012). The signature regulated signaling pathways including Calcium, MAPK, ErbB, mTOR and cell cycle involved in carcinogenesis from glial progenitor cell to primary Glioblastoma. CONCLUSIONS: The 4-MicroRNA signature was identified as an independent prognostic biomarker that identified patients who have a favorable outcome ((Yuan GQ, Wei NL, Wang XQ, Zhang YN, Mu LY, Zhou WN, Pan YW. A 4-MicroRNAs signature predicts survival in glioblastoma multiforme patients. Cancer Biomark. 2017 Aug 25. doi: 10.3233/CBM-170205. [Epub ahead of print] PubMed PMID: 28869437. )). 4_mirna_signature.txt Last modified: 2024/06/07 02:56by 127.0.0.1